Ikaria Overview
- Founded
-
2005

- Status
-
Acquired/Merged
- Employees
-
530

- Latest Deal Type
-
M&A
- Financing Rounds
-
8
- Investments
-
1
Ikaria General Information
Description
Operator of an integrated critical care company intended to offer advanced critical care services. The company's critical care services focusses on developing and commercializing innovative therapies enabling to meet the unique and complex medical needs of critically ill patients.
Contact Information
Website
www.ikaria.com
Formerly Known As
ITL Holdings
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Hospitals/Inpatient Services
Other Industries
Biotechnology
Other Healthcare Services
Acquirer
Primary Office
- Perryville III Corporate Park, 53 Frontage Road, Third Floor
- P.O. Box 9001
- Hampton, NJ 08827
- United States
Ikaria Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Ikaria Patents
Ikaria Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20180066298-A1 | Functionally modified polypeptides and radiobiosynthesis | Pending | 02-Sep-2016 | 000000000 | |
US-20170049809-A1 | Compositions and methods to modulate angiogenesis | Abandoned | 15-Jun-2007 | 000000000 | 0 |
US-20140220161-A1 | Compositions and methods to modulate angiogenesis | Abandoned | 15-Jun-2007 | 000000000 | 0 |
US-20100247680-A1 | Compositions and methods to modulate angiogenesis | Abandoned | 15-Jun-2007 | 000000000 | 0 |
JP-2010530001-A | Compositions containing sulfides alone or in combination with nitric oxide and uses thereof | Pending | 15-Jun-2007 | A61K33/04 |
Ikaria Signals
Ikaria Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Ikaria Investments (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000 000000000 | 28-Mar-2007 | 0000000000 | 00000 | Pharmaceuticals |